Posts by: Stacy Grieve, PhD

Stacy Grieve, PhD

March 16, 2018March 16, 2018

Metformin, Statins Do Not Reduce Incidence of Ovarian Cancer in Women with Type 2 Diabetes, Study Says

News

Women with type 2 diabetes taking metformin or statins are not less likely to develop epithelial ovarian cancer than any other type 2 diabetes patient, a large Finnish cohort study ... Read more

February 14, 2018February 14, 2018

Genetic Discovery May Be ‘Super Assassin’ of Tumor Cells, Researcher Says

News

The nucleotide expansions that cause a number of degenerative diseases may be the reason why these patients are far less susceptible to cancer, a new study suggests. A leading researcher ... Read more

February 2, 2018

‘Warm’ Chemo Given Ovarian Cancer Patients Seen to Delay Recurrence in Phase 3 Trial

News

Results from a recent phase 3 clinical trial show that a specialized type of chemotherapy delivery may delay disease recurrence in newly diagnosed, advanced ovarian cancer patients. The specialized technique, called ... Read more

October 30, 2017

Small RNA Molecules Are Ancient Kill Switches that Cause Cancer Cell Death, Study Reveals

News

A recent study reports that small RNA molecules, siRNAs and shRNAs, may contain sequences that simultaneously target multiple survival genes, which ultimately causes efficient cancer cell death. This discovery, eight ... Read more

August 2, 2017

UC San Diego Team Receives $5.8 Million to Develop Immunotherapy for Ovarian, Other Cancer Patients

News

Researchers at the University of California San Diego School of Medicine have received a $5.8 million state grant to develop an immunotherapy against hard-to-kill cancer stem cells. The team that won ... Read more

July 19, 2017

Draft of New Guidelines Recommends No Ovarian Cancer Screening for Many Women Without Symptoms

News

Ovarian cancer screening in women of average age who have no symptoms offers no benefits and can cause harm, according to a draft of new screening guidelines. This means screening ... Read more